Preliminary consensus statement on glucocorticoid induced osteoporosis;Vorläufiges konsensus-statement zur glukokortikoid-induzierten osteoporose

Zeitschrift fur Rheumatologie

Volumn 60, Issue 2, 2001, Pages 96-99

  Scharla, S H ^a,b,c   Buttgereit, F ^a,b,c   Dreher, R ^a,b,c   Felsenberg, D ^a,b,c   Franck, H ^a,b,c   Hein, G ^a,b,c   Lemmel, E M ^a,b,c   Rau, R ^a,b,c   Sieper, J ^a,b,c   Braun, J ^a,b,c,d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CALCIUM; GLUCOCORTICOID; RALOXIFENE; VITAMIN D;

BONE DENSITY; CONFERENCE PAPER; DENSITOMETRY; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; HUMAN; OSTEOPOROSIS; PATHOGENESIS;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS; RISK FACTORS; STEROIDS;

EID: 0035014666     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930170081     Document Type: Conference Paper

References (14)

1. 1. Adachi JD, Bensen WG, Blanchi F, Cividino A, Pillersdorf S, Sebaldt RJ, Tugwell P, Gordon M, Steele M, Webber C, Goldsmith CH (1996) Vitamin D and Calcium in the Prevention of Corticosteroid Induced Osteoporosis: A 3 Year Followup. J Rheumatol 23:995-1000
2. 2. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste.-Marie LG, Tenenhouse A, Chines AA (1997) Intermittent Etidronate Therapy To Prevent Corticosteroid-induced Osteoporosis. N Engl J Med 337-382
3. 3 Supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 125:961
4. 4. Oelzner P, Muller A, Deschner F, Huller M, Abendroth K, Hein G, Stein G (1998) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 62(3):193-198
5. 3. J Steroid Biochem Molec Biol 53:599
6. 6. Peel NFA, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated reheumatoid arthritis. Ann Rheum Dis 54:801
7. 7. Reginster JY, Kuntz D, Verdicht W, Wouters M, Guillevin L, Menkes CJ, Rawlinson D (1997) Prophylactic Use of Alfacalcidol in Corticosteroid-Induced Osteoporosis. Bone 20(Suppl No 4S):9S
8. 8. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339:292
9. 9. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328:1747
10. 10. Reginster JY, Kuntz D, Verdickt W, Wouters M, Guillevin L, Menkes CJ, Nielsen K (1999) Prophylactic use of Alfacalcidol in corticosteroid-induced osteoporosis. Osteoporos Int 9:75
11. 11. Reid DM, Hughes RA, Laan RFJM, Sacco-Gibson NA, Wenderoth DH, Adami S, Eusebio RA, Devogelaer JP (2000) Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial. J Bone Miner Res 15:1006
12. 12. Ringe JD, Cöster A, Meng T, Schacht E, Umbach R (1999) Treatment of Glucocorticoid-induced osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium. Calcif Tissue Int 65:337
13. 13. Selby PL, Halsey JP, Adams KRH, Klimiuk P, Knight. SM, Pal B, Stewart IM, Swinson DR (2000) Corticosteroids do not alter the threshold for vertebral fracture. J Bone Min Res 15:952
14. 14. Van Cleemput J, Daenen W, Geusens P, Dequeker J, Van De Werf F, Vanhaecke J (1996) Prevention of bone loss in cardiac transplant recipients. Transplantation 61:1495